title: Management of aboriginal and nonaboriginal people with chronic kidney disease in Quebec: quality-of-care indicators.
abstract: OBJECTIVE
  To compare quality-of-care indicators for management of patients with chronic kidney disease (CKD) and type 2 diabetes among the James Bay Cree of Northern Quebec with those among residents of Montreal, Que.
  
  
  METHODS
  A cross-sectional survey using medical records from patients seen between 2002 and 2008.
  
  
  METHODS
  Predialysis clinics of the McGill University Health Centre in Montreal.
  
  
  METHODS
  Thirty Cree and 51 nonaboriginal patients older than 18 years of age with type 2 diabetes mellitus and estimated glomerular filtration rates of less than 60 mL/min/1.73 m2.
  
  
  METHODS
  Rates of anemia, iron deficiency, obesity, and renoprotective medication use among aboriginal and nonaboriginal patients.
  
  
  RESULTS
  Overall, the Cree patients were younger (59 vs 68 years of age, P < .0035) and weighed more (101 vs 77 kg,P < .001). The 2 groups were prescribed medication to control blood pressure, lipids, and phosphate levels at similar rates, but the Cree patients were more likely to receive renoprotective agents (87% vs 65%, P = .04). Despite similar rates of erythropoietin supplementation, the Cree patients were at greater risk of anemia, with an adjusted risk ratio of 2.80 (95% CI 1.01 to 7.87).
  
  
  CONCLUSIONS
  Cree patients with CKD were younger, weighed more, and were more likely to receive renoprotective agents. With the exception of the management of anemia, quality of CKD care was similar between the 2 groups.Anemia education for family physicians and continuous monitoring of quality indicators must be implemented in northern Quebec.
authors.affiliation: McGill University, Montreal, Quebec, Canada. jason.patapas2@mail.mcgill.ca
authors.forename: Jason Michael
authors.initials: JM
authors.lastname: Patapas
authors.forename: Ana Chelene
authors.initials: AC
authors.lastname: Blanchard
authors.forename: Sameena
authors.initials: S
authors.lastname: Iqbal
authors.forename: Murray
authors.initials: M
authors.lastname: Vasilevsky
authors.forename: David
authors.initials: D
authors.lastname: Dannenbaum
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000150:complications / Q000188:drug therapy / Q000208:ethnology; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000208:ethnology* / Q000628:therapy; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D019538:Health Care Surveys; D054625:Healthcare Disparities; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D007198:Indians, North American; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016016:Proportional Hazards Models; D019984:Quality Indicators, Health Care; D011792:Quebec; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000208:ethnology* / Q000628:therapy
chemical_list: D006397:Hematinics; D004921:Erythropoietin